Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organisms
Background and Objectives: Upper urinary tract infections (UTIs) that require in-patient care can be expensive. Comorbid conditions such as diabetes as well as UTI due to extended-spectrum beta-lactamase (ESBL) producing bacteria may affect costs. The quality of life of patients with this condition...
Main Authors: | Ebenezer Daniel, Bijesh Yadav, Lakshmanan Jeyaseelan, Malavika Babu, Selvin Sundar Raj Mani, Alice Joan Mathuram, Sowmya Sathyendra, Samuel George Hansdak, Ramya Iyyadurai, Rani Diana Sahni, Thambu David Sudarsanam |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | CHRISMED Journal of Health and Research |
Subjects: | |
Online Access: | http://www.cjhr.org/article.asp?issn=2348-3334;year=2022;volume=9;issue=4;spage=223;epage=230;aulast=Daniel |
Similar Items
-
Geographical Distribution of β-Lactam Resistance among <i>Klebsiella spp.</i> from Selected Health Facilities in Ghana
by: Elvis Quansah, et al.
Published: (2019-09-01) -
Cefoxitin: Interesting Perspectives on a Neglected Intravenous Beta-lactam
by: Zoé CAVALLI, et al.
Published: (2018-12-01) -
Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
by: Allison M. Gibble, et al.
Published: (2015-12-01) -
Management of clinical infections of Escherichia coli by new β-lactam/ β-lactamase inhibitor combinations
by: Ashraf Ahmed Kadry, et al.
Published: (2022-08-01) -
Extended Spectrum- and Carbapenemase-Based β-Lactam Resistance in the Arabian Peninsula—A Descriptive Review of Recent Years
by: John Philip Hays, et al.
Published: (2022-10-01)